EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Heparanase as a therapeutic target for mitigating cancer progression

Yogesh Kumar, Lokesh Gambhir, Gaurav Sharma, Asha Sharma, Neha Kapoor

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-10 · 1880 (5) · 189441

DOI: 10.1016/j.bbcan.2025.189441 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-10. Verfasst von Yogesh Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Applied Sciences, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India. Hauptthemen laut MEDLINE: Glucuronidase, Neoplasms, Enzyme Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 231 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer has been one of the primary causes of mortality for the last three decades across the globe, with contemporary treatment modalities often falling short due to limitations viz. drug resistance, toxicity, and the inability to target molecular mechanisms of tumor progression. Among various intracellular mediators implicated in cancer progression, heparanase, a heparan sulfate degrading enzyme, has been pivotal by facilitating tumor invasion, angiogenesis, and metastasis. Inhibiting the activity of heparanase is a promising therapeutic approach that can potentially curtail tumor growth and metastasis, offering a novel strategy to curb cancer progression. The present review underpins the discovery, structural features, and functional roles of heparanase, with a focus on its differential expression in normal and cancer cell state. Further, the review provides an insight in several classes of heparanase inhibitors including nucleic acid-based inhibitors, polysulfated saccharides, vaccines, miRNA, monoclonal antibodies, natural compounds and small molecule inhibitors along with their mechanism of action and potential benefits in cancer therapy. Recent advancements in heparanase inhibitor development, especially those agents that have moved into clinical trials and received patents is also highlighted thereby underscoring their therapeutic potential and commercial viability. The present review emphasizes over the potential of heparanase as a therapeutic agent and provides an extensive summary of actual endeavors to develop effective inhibitors that may substantiate the forthcoming landscape of cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucuronidaseNeoplasmsEnzyme InhibitorsAntineoplastic AgentsHumansDisease ProgressionAnimalsMolecular Targeted TherapyNeovascularization, PathologicHeparanase

Stichwörter der Autor:innen

Cancer therapeuticsClinical trialsHeparanaseHeparanase inhibitorTargeted therapy

Substanzen

GlucuronidaseEnzyme InhibitorsAntineoplastic AgentsHeparanase

Autor:innen und Institutionen

  • School of Applied Sciences, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India.
  • School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun 248001, Uttarakhand, India.
  • Department of Zoology, Swargiya P. N. K. S. Govt. PG College, Dausa 303303, Rajasthan,India.
  • School of Applied Sciences, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India. Electronic address: n29.neha.kapur@gmail.com.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Science and Engineering Research Board

Zitieren

APA

Kumar, Y., Gambhir, L., Sharma, G., Sharma, A., & Kapoor, N. (2025). Heparanase as a therapeutic target for mitigating cancer progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(5), 189441. https://doi.org/10.1016/j.bbcan.2025.189441

Vancouver

Kumar Y, Gambhir L, Sharma G, Sharma A, Kapoor N. Heparanase as a therapeutic target for mitigating cancer progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(5):189441. doi:10.1016/j.bbcan.2025.189441

BibTeX
@article{Kumar2025,
  author = {Kumar, Yogesh and Gambhir, Lokesh and Sharma, Gaurav and Sharma, Asha and Kapoor, Neha},
  title = {Heparanase as a therapeutic target for mitigating cancer progression},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  volume = {1880},
  number = {5},
  pages = {189441},
  doi = {10.1016/j.bbcan.2025.189441}
}
Kostenlos starten →